Annemieke J. Wouterse
Director/Board Member at Polyganics BV
Annemieke J. Wouterse active positions
| Companies | Position | Start | End |
|---|---|---|---|
NV NOM
 NV NOM Investment ManagersFinance NV NOM (NV NOM) is a private equity firm founded in 1974. The firm is headquartered in Groningen, Netherlands. | Private Equity Investor | 1999-09-30 | - |
Polyganics BV
 Polyganics BV Medical SpecialtiesHealth Technology Polyganics BV engages in the development, manufacture, and commercialization of bioresorbable medical devices that facilitate tissue repair and regeneration. It offers pipeline, peripheral nerve repair, neurosurgery, and general surgery products . The company was founded in 1999 and is headquartered in Groningen, the Netherlands. | Director/Board Member | 2012-07-03 | - |
Career history of Annemieke J. Wouterse
Former positions of Annemieke J. Wouterse
| Companies | Position | Start | End |
|---|---|---|---|
Mucosis BV
 Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands. | Director/Board Member | 2010-09-30 | - |
Training of Annemieke J. Wouterse
| Erasmus University Rotterdam | Undergraduate Degree |
Statistics
International
| Netherlands | 5 |
Operational
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 2 |
| Finance | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
NV NOM
NV NOM Investment ManagersFinance NV NOM (NV NOM) is a private equity firm founded in 1974. The firm is headquartered in Groningen, Netherlands. | Finance |
Mucosis BV
Mucosis BV Miscellaneous Commercial ServicesCommercial Services Mucosis BV develops mucosal vaccines for infectious diseases. Its product is SynGEM, an intranasal vaccine to prevent respiratory syncytial virus infection. Its vaccines are based on the patented and validated Mimopath technology. This technology enables a more natural immune response as well as a broad base of protection as was seen in the proof-of-concept animal and human studies of our FluGEM vaccine candidate. The company was founded by Cornelis Leenhouts in 2007 and is headquartered in Groningen, the Netherlands. | Commercial Services |
Polyganics BV
Polyganics BV Medical SpecialtiesHealth Technology Polyganics BV engages in the development, manufacture, and commercialization of bioresorbable medical devices that facilitate tissue repair and regeneration. It offers pipeline, peripheral nerve repair, neurosurgery, and general surgery products . The company was founded in 1999 and is headquartered in Groningen, the Netherlands. | Health Technology |
